A new weapon against the super-tough C diff bacteria tested in phase-one human trial
by Laurie Fickman,University of HoustonFecal drug concentrations of omadacycline and vancomycin. Credit:The Journal of Infectious Diseases(2023). DOI: 10.1093/infdis/jiad537In a phas
Updated on: December 30,2023
11
A new weapon against the super-tough C diff bacteria tested in phase-one human trial
by Laurie Fickman,University of HoustonFecal drug concentrations of omadacycline and vancomycin. Credit:The Journal of Infectious Diseases(2023). DOI: 10.1093/infdis/jiad537In a phas
Updated on:December 30,2023
11
